253 related articles for article (PubMed ID: 9646856)
1. Phospholipid-independent binding of beta 2glycoprotein I by IgA from patients with antiphospholipid syndrome.
Galazka MW; Keil LB; Kohles J; Petersheim M; DeBari VA
Ann Clin Lab Sci; 1998; 28(3):153-9. PubMed ID: 9646856
[TBL] [Abstract][Full Text] [Related]
2. Reactivity to beta 2 glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis.
Forastiero RR; Martinuzzo ME; Kordich LC; Carreras LO
Thromb Haemost; 1996 May; 75(5):717-20. PubMed ID: 8725711
[TBL] [Abstract][Full Text] [Related]
3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
4. Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation.
Arvieux J; Darnige L; Hachulla E; Roussel B; Bensa JC; Colomb MG
Thromb Haemost; 1996 May; 75(5):725-30. PubMed ID: 8725713
[TBL] [Abstract][Full Text] [Related]
5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
Pengo V; Biasiolo A; Fior MG
Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies.
Pengo V; Biasiolo A; Brocco T; Tonetto S; Ruffatti A
Thromb Haemost; 1996 May; 75(5):721-4. PubMed ID: 8725712
[TBL] [Abstract][Full Text] [Related]
8. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome.
Cabral AR; Cabiedes J; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1894-8. PubMed ID: 8991988
[TBL] [Abstract][Full Text] [Related]
10. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
Hanly JG; Smith SA
J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
[TBL] [Abstract][Full Text] [Related]
11. "Anticardiolipin" autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding.
Roubey RA; Eisenberg RA; Harper MF; Winfield JB
J Immunol; 1995 Jan; 154(2):954-60. PubMed ID: 7814895
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
13. [Clinical subsets and phospholipid-dependent anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome].
Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Matsuura E; Ikeda Y
Rinsho Ketsueki; 1995 Oct; 36(10):1170-4. PubMed ID: 8531326
[TBL] [Abstract][Full Text] [Related]
14. [Antiphospholipid and anti beta 2-glycoprotein I antibodies].
Arvieux J; Roussel B; Colomb MG
Ann Biol Clin (Paris); 1994; 52(5):381-5. PubMed ID: 7856939
[TBL] [Abstract][Full Text] [Related]
15. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM
J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
[TBL] [Abstract][Full Text] [Related]
16. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome.
Cucnik S; Kveder T; Krizaj I; Rozman B; Bozic B
Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
18. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
[TBL] [Abstract][Full Text] [Related]
19. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS
Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis.
Sherer Y; Gerli R; Vaudo G; Schillaci G; Gilburd B; Giordano A; Bocci EB; Allegrucci R; Marchesi S; Mannarino E; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1051():299-303. PubMed ID: 16126971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]